Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the US
(Reuters) – A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration. The impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets… Read More »